Is Your Women’s Health “Expert” Lying To You? | Dr. Jen Gunter

Doctor Mike opens by arguing that women’s health online has been crowded with fear, shame, and products marketed as quick fixes. Dr. Jen Gunter says she has watched medical disinformation worsen since joining Twitter in 2010, particularly after short-form reels became widespread. Fear, definitive instructions, and confident personalities attract attention, whereas scientific nuance is slower and less exciting. She says the cycle escalates: once everyone is told to take menopause hormone therapy, the next product becomes testosterone, higher estrogen doses, microdosed GLP-1 drugs, or weighted vests. Doctor Mike calls this the “Ozification” or “TikTok-ification” of health communication; Gunter agrees that celebrity culture gives misinformation a veneer of respectability.

Gunter says wellness businesses exploit gaps left by a healthcare system that historically understudied and neglected women. Print-era brands such as Goop helped make aesthetic and celebrity authority more important than the message; TikTok accelerated the process through sharing, reactions, and algorithmic amplification. Doctor Mike notes that professional “clippers” can flood platforms with short excerpts from long-form content, creating forced virality rather than spontaneous popularity. Gunter says a woman who cannot get a satisfying answer from her doctor may be particularly vulnerable to claims such as vaginal steaming, which looks compelling online but does not fill the underlying medical gap.

Gunter attributes her persistence online partly to being misled when her own children were critically ill. Pregnant with triplets, she delivered one son at 22½ weeks and chose not to resuscitate him, then developed resistant E. coli sepsis and delivered her other sons at 26 weeks. They weighed 1 pound 11 ounces and 1 pound 13 ounces; one, Oliver, had pulmonary valve stenosis and a massive atrial septal defect, and both spent a long time in the NICU. One son had severe reflux, cerebral palsy, oxygen dependence, and repeated vomiting. Gunter tried formula changes and compounded medication before a University of Michigan expert told her that she was doing the right things and that time was needed. She realized information must be communicated in a way patients can hear.

Gunter says the hardest lesson from her son’s reflux was accepting that no procedure or medication would fix it immediately. “No thing is also an intervention”: once she understood that he needed to mature and outgrow the problem, she could control her response instead of escalating treatment. She contrasts chronic care with acute care, where antibiotics or surgery can often produce a rapid fix. Doctor Mike adds that patients may demand a diagnosis and treatment during a single visit even when a condition needs time to declare itself. Both say uncertainty becomes more tolerable when a clinician gives a concrete follow-up plan rather than simply saying, “We’ll watch it.”

Gunter says hormone testing is generally unhelpful for a healthy person with regular menstrual cycles because fluctuating levels do not explain their overall health. Online marketers often frame testing as “being in tune with your body,” then sell supplements based on whether estradiol or another hormone falls within an arbitrary range. Testing can be appropriate when there is a specific diagnostic question, such as investigating four months without a period. For someone who feels unwell, Gunter says clinicians should consider more useful tests, including iron or ferritin, because iron deficiency is common in menstruating women; she cites estimates approaching 40% in women under 24.

Gunter rejects the claim that the Women’s Health Initiative was inherently flawed because critics dislike its conclusions. It was a large randomized, double-blind, placebo-controlled study involving roughly 27,000 participants in its hormone arms, including Premarin plus medroxyprogesterone and Premarin alone. The trial asked whether hormone therapy should be used broadly for primary prevention, so many participants were older and did not have severe menopausal symptoms. The study’s safety monitoring stopped an arm when a prespecified composite threshold involving outcomes such as stroke, death, and breast cancer was reached. Gunter says later analyses found risks were substantially lower in women aged 50–59 than in older starters, but that does not justify claiming hormone therapy prevents cardiovascular disease or dementia.

Gunter supports menopause hormone therapy for people suffering from hot flashes and night sweats when their cardiovascular and other risks are considered. She says evidence does not establish that it prevents dementia, improves cognition, or reduces all-cause mortality. Observational studies are confounded because users may be healthier, wealthier, less exposed to pollution, or more physically active, while randomized data do not show a dementia benefit. More frequent hot flashes may correlate with dementia risk, possibly through sleep, vascular, or autonomic mechanisms, but that remains uncertain. Gunter’s recommendation is to treat suffering patients without presenting therapy as universally protective; claims of definitive benefit exceed informed consent.

Gunter says testosterone naturally declines from the late twenties or early thirties and is not a menopause-specific deficiency, except in different circumstances such as ovarian removal. There is no established low testosterone level requiring treatment in women, so testing is warranted for signs of excess—such as acne or a receding hairline—not merely for fatigue or feeling unwell. Current evidence supports testosterone as a moderately effective pharmaceutical option for low libido when kept in the female range, not as a treatment for brain health, bone protection, dementia prevention, heart disease, or muscle mass. She warns that female-range assays can be inaccurate and that higher doses can cause vocal changes and other harms.

Gunter says online discussions of oral contraceptive pills often erase the fact that two things can be true: a person may feel bad on a pill, while the same medication can be essential for someone else. She cites people whose PMDD, acne, endometriosis pain, heavy bleeding, or endometrial-cancer risk improved with hormonal contraception. The pill does carry a venous thromboembolism risk, but she says that risk remains much lower than the dangers associated with pregnancy and postpartum complications. She attributes much anti-contraception content to right-wing funding and algorithmic amplification, while noting that a patient deserves a nuanced discussion of hormonal and non-hormonal options rather than an automatic prescription or blanket fear.

Gunter says some clinicians exploit women when hormone testing, supplements, or clinic referrals are tied to money. She avoids pharmaceutical-company relationships and many patient advocacy groups because of their funding, explaining that even a $22 drug-company lunch can influence judgment and that offers of $20,000 for ten hours of monthly work can create obvious conflicts. Doctor Mike describes accepting an Abbott campaign encouraging blood donation while refusing ads for expensive branded drugs when a cheaper generic would be his actual recommendation. Gunter says the ethical question is whether a message remains one a clinician would genuinely give a patient, and both agree that partial disclosure is inadequate when supplement, advertising, or book-purchase arrangements remain hidden.

Gunter predicts severe harm from the current health-policy environment, arguing that institutions and scientific review are being weakened incrementally. She points to fluoride removal in Calgary, which she says was followed by more dental decay than in Edmonton, and worries about panels that could question vaccines, SSRIs in pregnancy, or other established care while presenting political decisions as scientific review. Doctor Mike notes the contradiction between demanding more research on ultra-processed food and vaccines while cutting the funding needed to conduct that research. Gunter says the damage includes lost labs, brain drain, and undiscovered science that will never happen; she believes the strategy is chaos and distraction that consolidates power.

Gunter recounts criticizing Goop for claims such as bras causing breast cancer and jade eggs being rechargeable by moon energy. After Goop responded by tone-policing her language and elevating Dr. Steven Gundry, she wrote that expertise—not celebrity—gave her standing to challenge those claims. Doctor Mike describes his own interview with Gundry, who claimed he could cure every disease; Gunter responds that fantastical claims require fantastical evidence, such as a properly published long-term clinical trial. She says alternative medicine succeeds by placing aesthetics, certainty, and exotic imagery over evidence, while its proponents rarely fund the rigorous studies they say conventional medicine lacks.

Gunter and her husband tested how quickly an influencer could create a supplement brand through a white-label supplier. They selected a turmeric-and-black-pepper product, set a price, and learned that the supplier could design the label, connect to Shopify, store the bottles, and ship orders without the influencer touching inventory. At a minimum order of roughly 8,333 bottles, Gunter estimated a profit of about $197,000 after startup costs. She says turmeric lacks convincing evidence for a health benefit and has been associated with liver toxicity, yet millions of Americans take it. Her conclusion is that supplement profits help finance wellness misinformation and that stronger regulation could cut off that incentive.

For recurrent symptoms such as itching, burning, or painful sex, Gunter recommends a culture rather than assuming yeast; laboratories can test whether Candida is fluconazole-sensitive. A typical sensitive-strain regimen is fluconazole today, again in three days, then weekly, while resistant infections may require boric acid because Brexafemme is unavailable. She says diet, cotton underwear, and commercial probiotics lack meaningful evidence for recurrent yeast; a specific vaginal Lactin-V study showed some benefit for bacterial vaginosis, but over-the-counter products remain inadequately tested. Odor warrants evaluation for bacterial vaginosis, trichomonas, yeast, or skin sweat—not douching or scented wipes. The vagina is self-cleaning; for external skin, she recommends a gentle, fragrance-free cleanser rather than products marketed around shame or “purity.”